
Enanta Pharmaceuticals ENTA
$ 12.16
-2.8%
Quarterly report 2025-Q4
added 02-11-2026
Enanta Pharmaceuticals P/S Ratio 2011-2026 | ENTA
Annual P/S Ratio Enanta Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00397 | 0.00275 | 0.00239 | 0.0105 | 0.0146 | 0.00798 | 5.83 | 6.87 | 9.19 | 5.13 | 3.26 | 17 | 6.09 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17 | 0.00239 | 4.11 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Regeneron Pharmaceuticals
REGN
|
5.67 | $ 742.1 | -1.93 % | $ 77.6 B | ||
|
AbbVie
ABBV
|
24.1 | $ 211.9 | 0.37 % | $ 375 B | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.28 | -2.24 % | $ 980 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Rigel Pharmaceuticals
RIGL
|
2.03 | $ 26.28 | -0.34 % | $ 473 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Avidity Biosciences
RNA
|
535 | $ 13.07 | -0.23 % | $ 1.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
33.4 | $ 77.56 | -5.31 % | $ 5.04 B | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Avid Bioservices
CDMO
|
3.03 | - | - | $ 789 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
8.96 | $ 12.27 | -12.11 % | $ 1.86 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
SIGA Technologies
SIGA
|
4.27 | $ 5.36 | 7.96 % | $ 383 M | ||
|
Silence Therapeutics plc
SLN
|
119 | $ 4.92 | -7.34 % | $ 622 M | ||
|
SELLAS Life Sciences Group
SLS
|
26.8 | $ 4.47 | -9.69 % | $ 487 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
2.58 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Summit Therapeutics
SMMT
|
406 | $ 16.59 | -3.88 % | $ 12.4 B | ||
|
Spruce Biosciences
SPRB
|
0.0314 | $ 62.07 | -10.19 % | $ 47.6 M |